These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32538756)

  • 1. Evaluation of IgG, IgM, CD4+ and CD8+ T cells during neoadjuvant chemotherapy with Tezio and Apatinib in gastric cancer patients.
    Cui Z; Zhang J; Zhang J; Xu L
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):113-118. PubMed ID: 32538756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of XELOX regimen as neoadjuvant chemotherapy on radical resection rate and prognosis in patients with advanced gastric cancer].
    Zhao Q; Li Y; Tan BB; Tian Y; Jiao ZK; Zhao XF; Zhang ZD; Wang D; Yang PG
    Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):773-7. PubMed ID: 24378101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of the immune cell population in peripheral blood on response and survival in patients receiving neoadjuvant chemotherapy for advanced gastric cancer.
    He Q; Li G; Ji X; Ma L; Wang X; Li Y; Fan C
    Tumour Biol; 2017 May; 39(5):1010428317697571. PubMed ID: 28475005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of apatinib plus neoadjuvant chemotherapy followed by resection on pathologic response in patients with locally advanced gastric adenocarcinoma: A single-arm, open-label, phase II trial.
    Zheng Y; Yang X; Yan C; Feng R; Sah BK; Yang Z; Zhu Z; Liu W; Xu W; Ni Z; Beeharry MK; Hua Z; Yan M; Zhu Z; Li C
    Eur J Cancer; 2020 May; 130():12-19. PubMed ID: 32171104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Safety and short-term efficacy of apatinib combined with oxaliplatin and S-1 in the conversion treatment for gastric cancer with peritoneal metastasis].
    Ye ZS; Zeng Y; Wei SH; Wang Y; Chen S; Lin ZT; Wang ZW; Chen XL; Chen LC
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):240-247. PubMed ID: 34645168
    [No Abstract]   [Full Text] [Related]  

  • 6. Effectiveness and Safety of Apatinib Plus Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer: A Nonrandomized Controlled Trial.
    Lin JX; Xu YC; Lin W; Xue FQ; Ye JX; Zang WD; Cai LS; You J; Xu JH; Cai JC; Tang YH; Xie JW; Li P; Zheng CH; Huang CM
    JAMA Netw Open; 2021 Jul; 4(7):e2116240. PubMed ID: 34241629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apatinib plus chemotherapy versus chemotherapy alone as neoadjuvant therapy in locally advanced gastric carcinoma patients: a prospective, cohort study.
    Sun Y; Fan Y; Ye Z; Dong J; Zhang L; Peng Y
    Ir J Med Sci; 2023 Jun; 192(3):1033-1040. PubMed ID: 35819743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and safety of SOX regimen as neoadjuvant chemotherapy for advanced gastric cancer].
    Li T; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2011 Feb; 14(2):104-6. PubMed ID: 21365500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the efficacy and influencing factors of preoperative P-SOX neoadjuvant chemotherapy regimen for progressive gastric cancer-construction of a clinical prediction model.
    Feng L; Shao L; Sun S; Zhang C; Cai B
    Cancer Med; 2023 Jun; 12(12):13031-13040. PubMed ID: 37096925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative analysis on clinical efficacy of FOLFOX6 regimen and DCF regimen as neoadjuvant chemotherapy combined with radical gastrectomy in treating advanced gastric cancer.
    Tai Q; Shao H; Liu Y; Li E; Zhao R
    J BUON; 2019; 24(5):2006-2012. PubMed ID: 31786868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of neoadjuvant chemotherapy with modified FOLFOX7 regimen on the treatment of advanced gastric cancer.
    Zhang J; Chen RX; Zhang J; Cai J; Meng H; Wu GC; Zhang ZT; Wang Y; Wang KL
    Chin Med J (Engl); 2012 Jun; 125(12):2144-50. PubMed ID: 22884144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Short-term efficacy and safety of the synchronous neoadjuvant chemoradiotherapy with paclitaxel plus carboplatin in stage III adenocarcinoma of esophagogastric junction].
    Ji Y; Peng T; Wang G; Zhang Y; Cao M; Gao Q; Li S
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Sep; 21(9):1019-1024. PubMed ID: 30269322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].
    Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I Study of Neoadjuvant Chemotherapy with Capecitabine and Oxaliplatin for Locally Advanced Gastric Cancer.
    Satake H; Kondo M; Mizumoto M; Kotake T; Okita Y; Ogata T; Hatachi Y; Yasui H; Miki A; Imai Y; Ichikawa C; Murotani K; Kotaka M; Kato T; Kaihara S; Tsuji A
    Anticancer Res; 2017 Jul; 37(7):3703-3710. PubMed ID: 28668863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinical study of paclitaxel combined with FOLFOX4 regimen as neoadjuvant chemotherapy for advanced gastric cancer].
    Qu JJ; Shi YR; Liu FR; Ma SQ; Ma FY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Sep; 13(9):664-7. PubMed ID: 20878572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial.
    Cats A; Jansen EPM; van Grieken NCT; Sikorska K; Lind P; Nordsmark M; Meershoek-Klein Kranenbarg E; Boot H; Trip AK; Swellengrebel HAM; van Laarhoven HWM; Putter H; van Sandick JW; van Berge Henegouwen MI; Hartgrink HH; van Tinteren H; van de Velde CJH; Verheij M;
    Lancet Oncol; 2018 May; 19(5):616-628. PubMed ID: 29650363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX combined with apatinib and camrelizumab in the treatment of resectable locally advanced gastric cancer: a case report.
    Hu J; Li X; Wang Y; Xu B; He P; Wang Z; He L; Chen H
    Front Immunol; 2024; 15():1410284. PubMed ID: 39072331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apatinib combined with SOX regimen for conversion therapy in advanced gastric cancer patients: a retrospective cohort study.
    Deng YY; Jiang DY; Zhu PF; Lu H; Liu Q; Zhang X; Pan SY; Chen ZL; Yang L
    World J Surg Oncol; 2023 Apr; 21(1):129. PubMed ID: 37041581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term survival and safety of apatinib combined with oxaliplatin and S-1 in the conversion therapy of unresectable gastric cancer.
    Ye Z; Zeng Y; Wei S; Wang Y; Lin Z; Chen S; Wang Z; Chen S; Chen L
    BMC Cancer; 2021 Jun; 21(1):702. PubMed ID: 34126957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of docetaxel combined with oxaliplatin and fluorouracil against stage III/IV gastric cancer.
    Yu YJ; Sun WJ; Lu MD; Wang FH; Qi DS; Zhang Y; Li PH; Huang H; You T; Zheng ZQ
    World J Gastroenterol; 2014 Dec; 20(48):18413-9. PubMed ID: 25561810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.